A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

Academic Article

Publication Date:

2014

Short description:

A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients / Maftouh, ., Avan, ., Funel, ., Paolicchi, ., Vasile, ., Pacetti, ., Vaccaro, ., Faviana, ., Campani, ., Caponi, ., Mambrini, ., Boggi, ., Cantore, ., Milella, ., Peters, ., G., J., Reni, M., Giovannetti,. - In: PHARMACOGENOMICS. - ISSN 1462-2416. - (2014).

Iris type:

1.1 Articolo in rivista

List of contributors:

Maftouh, ; Avan, ; Funel, ; Paolicchi, ; Vasile, ; Pacetti, ; Vaccaro, ; Faviana, ; Campani, ; Caponi, ; Mambrini, ; Boggi, ; Cantore, ; Milella, ; Peters, ; G., J.; Reni, M; Giovannetti,

Authors of the University:

RENI MICHELE

Handle:

https://iris.unisr.it/handle/20.500.11768/123997

Published in:

PHARMACOGENOMICS

Journal